Georgia's Online Cancer Information Center

Atlanta Team Reports Breakthrough in Cancer Detection

1/12/2016, Andy Miller, Georgia Health News

 
 
Ovarian cancer ranks fifth in cancer deaths among women, accounting for more deaths than any other cancer of the female reproductive system.

But in many cases, it’s not found until it’s far along. That’s because ovarian cancer, especially in the early stages, often shows no obvious symptoms.

A breakthrough test, though, may be on its way. Last month, Atlanta’s Ovarian Cancer Institute, in collaboration with Georgia Tech, announced a new metabolic detection method for early-stage ovarian cancer that the researchers say is very accurate.

Their research has been published in Nature’s online journal Scientific Reports.

“By the time ovarian cancer is detected, it’s usually too late,” said Dr. Benedict Benigno, founder and CEO of the Ovarian Cancer Institute and director of gynecologic oncology at Northside Hospital in Atlanta.

“Existing screening methods such as pelvic examinations, ultrasounds and CA-125 blood tests are notoriously unreliable,” he said. “We are thrilled to provide women with such a highly accurate test,” he said.

“We’re very, very excited about this,’’ he added, noting that the test will cost just $2 to run.

To read more or to watch a GHN video interview with Benigno, courtesy of Northside Hospital, click here.

 

Media, News & Events

GCRCCP honored by ACS National Colorectal Cancer Roundtable

The Georgia Colorectal Cancer Control Program won the 2025 American Cancer Society's NCCRT National Achievement Award.

3/04/2025

Georgia CORE introduces a resource guide for barriers to cancer clinical trials

We invite you to download and share it, and let us know if there is anything we should add to it.

1/14/2025

Subscribe to Our Newsletter

Our email newsletter allows you to get the most up-to-date information right in your Inbox.

Subscribe Now